Carl Zeiss Meditec (OTCMKTS:CZMWY – Get Free Report) was upgraded by analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued to clients and investors on Monday,Zacks.com reports.
Carl Zeiss Meditec Trading Down 9.3%
OTCMKTS:CZMWY opened at $32.35 on Monday. The company’s 50-day moving average is $30.67 and its two-hundred day moving average is $32.92. Carl Zeiss Meditec has a 1-year low of $26.65 and a 1-year high of $60.99.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.
The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.
Further Reading
- Five stocks we like better than Carl Zeiss Meditec
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
